Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–9 of 9 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT06907342
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Core Needle Biopsy, +14 more
- Locations
-
- St. Olavs Hospital Trondheim, Norway
NCT07117435
- Conditions
- Colorectal Liver Metastases, First-line Treatment
- Locations
-
- The First Affiliated Hospital of Sun Yat-sen University，Lishui Central Hospital Lishui, Zhejiang, China
NCT06148779
- Conditions
- Arthritis, Behavior, First-line Treatment, +6 more
- Locations
-
- Joint Academy Malmö, Sweden
NCT06278870
- Conditions
- First-line Treatment, HER2-Positive Metastatic Breast Cancer
- Locations
-
- Sun Yat-sen Memorial Hospital,Sun Yat-sen University Guangzhou, Guangdong, China
Not Yet Recruiting
Ivonescimab Combined with Chemotherapy As First-line Treatment of Relapsed or Metastatic Thymic Cancer: a Prospective, Single Arm, Phase II Trial
NCT06750952
- Conditions
- Disease Attributes, First-line Treatment, Hemic and Lymphatic Diseases, +9 more
- Locations
-
Not specified
Completed
A Study of AK104 Monotherapy or AK104 Plus Axitinib in Advanced/Metastatic Renal Cell Carcinoma
NCT05256472
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
NCT04271813
- Conditions
- Anlotinib, Chemo-free Therapy, Colonic Diseases, +14 more
- Locations
-
- Department of Medical Oncology, Shanghai Changzheng Hospital Shanghai, China
Active, Not Recruiting
A Study of AK104 Plus Axitinib in Advanced/Metastatic Special Pathological Subtypes of Renal Cell Carcinoma
NCT05808608
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
- Locations
-
- West China Hospital Chengdu, Sichuan, China
Active, Not Recruiting
Phase II Study of Chemotherapy and PD-1 Inhibitor Combination With Autologous CIK Cell Immunotherapy to Treat Lung Cancer
NCT04836728
- Conditions
- First-line Treatment, Non-small Cell Lung Cancer Metastatic
- Locations
-
- Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China